1. Home
  2. OVBC vs MCRB Comparison

OVBC vs MCRB Comparison

Compare OVBC & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

N/A

Current Price

$41.53

Market Cap

163.3M

Sector

Finance

ML Signal

N/A

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

N/A

Current Price

$15.58

Market Cap

162.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OVBC
MCRB
Founded
1872
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.3M
162.7M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
OVBC
MCRB
Price
$41.53
$15.58
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$14.33
AVG Volume (30 Days)
15.9K
248.7K
Earning Date
01-27-2026
11-05-2025
Dividend Yield
2.22%
N/A
EPS Growth
22.03
N/A
EPS
3.01
0.62
Revenue
$64,211,000.00
$351,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.80
$24.94
Revenue Growth
11.98
N/A
52 Week Low
$21.86
$6.53
52 Week High
$42.00
$29.98

Technical Indicators

Market Signals
Indicator
OVBC
MCRB
Relative Strength Index (RSI) 73.04 42.68
Support Level $38.36 $15.68
Resistance Level $42.00 $17.90
Average True Range (ATR) 1.01 1.12
MACD 0.06 -0.22
Stochastic Oscillator 90.48 4.51

Price Performance

Historical Comparison
OVBC
MCRB

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: